# Zebra Kante™ 80 Protect
Schedule of significant portfolio movements for the financial year ended 31 July 2022
(continued)
| Total disposals in the year |  | US$ 15,479,648 |
| --- | --- | --- |
| Material disposals | Nominal holdings | Proceeds US$ |
| Altimmune | 97,192 | 739,579 |
| ATN International | 13,286 | 534,631 |
| AlloVir | 72,265 | 476,658 |
| American Software | 24,231 | 470,269 |
| Westlake Chemical | 4,087 | 403,898 |
| ASGN | 3,201 | 375,957 |
| Ferrari | 1,360 | 363,066 |
| Alico | 8,563 | 359,846 |
| BCB Bancorp | 17,549 | 334,893 |
| Southwestern Energy | 63,935 | 331,599 |
| Ramaco Resources | 21,725 | 331,524 |
| Alphabet | 129 | 311,304 |
| Ameris Bank | 7,017 | 293,661 |
| Intercontinental Exchange | 2,421 | 289,382 |
| Edwards Lifesciences | 2,680 | 283,919 |
| Amicus Therapeutics | 31,392 | 279,152 |
| GreenSky | 24,942 | 272,270 |
| ACADIA Pharmaceuticals | 9,265 | 242,280 |
| Albany International | 2,863 | 237,572 |
| Adicet Bio | 14,142 | 226,684 |
| ACV Auctions | 24,555 | 225,627 |
| Atea | 28,381 | 200,937 |
| ACM Research | 3,000 | 200,510 |
| Airbnb | 1,168 | 193,000 |
| California Resources | 4,590 | 191,816 |
| ADMA Biologics | 133,563 | 189,659 |
| Acumen Pharmaceuticals | 29,427 | 188,627 |
| Arlo Technologies | 19,733 | 187,661 |
| HEICO | 1,344 | 186,950 |
| Lowe's | 865 | 181,477 |
| a.k.a. Brands | 20,369 | 180,299 |
| Appfolio | 1,590 | 179,177 |
| A10 Networks | 12,716 | 177,897 |
| AFC Gamma | 8,988 | 175,266 |
| AdvanSix | 4,112 | 174,513 |
| Northfield Bancorp | 9,800 | 171,696 |
| Accel Entertainment | 12,728 | 169,919 |
| Vontier | 4,895 | 166,087 |
| Alerus Financial | 5,797 | 165,215 |
| Innospec | 1,761 | 159,194 |
| Arko | 19,197 | 157,676 |
| ACI Worldwide | 6,045 | 157,291 |
| United Parcel Service | 816 | 156,998 |
| First Bancorp | 5,328 | 155,379 |
| Banc of California | 8,527 | 155,021 |

The statement of material disposals reflect the aggregate disposals of a security greater than one per cent of the total disposals for the financial year. If there were fewer than twenty positions exceeding one per cent, the top twenty positions

Translation (ENFR, 2022-07-31):
# Zebra Kante™ 80 Protect
État des principales variations du portefeuille pour l’exercice clos le 31 juillet 2022 (suite)
| Total des cessions pour l’exercice |  | 15 479 648 USD |
| --- | --- | --- |
|  | Participations | Produit |
| Principales cessions | nominales | USD |
| Altimmune | 97 192 | 739 579 |
| ATN International | 13 286 | 534 631 |
| AlloVir | 72 265 | 476 658 |
| American Software | 24 231 | 470 269 |
| Westlake Chemical | 4 087 | 403 898 |
| ASGN | 3 201 | 375 957 |
| Ferrari | 1 360 | 363 066 |
| Alico | 8 563 | 359 846 |
| BCB Bancorp | 17 549 | 334 893 |
| Southwestern Energy | 63 935 | 331 599 |
| Ramaco Resources | 21 725 | 331 524 |
| Alphabet | 129 | 311 304 |
| Ameris Bank | 7 017 | 293 661 |
| Intercontinental Exchange | 2 421 | 289 382 |
| Edwards Lifesciences | 2 680 | 283 919 |
| Amicus Therapeutics | 31 392 | 279 152 |
| GreenSky | 24 942 | 272 270 |
| ACADIA Pharmaceuticals | 9 265 | 242 280 |
| Albany International | 2 863 | 237 572 |
| Adicet Bio | 14 142 | 226 684 |
| ACV Auctions | 24 555 | 225 627 |
| Atea | 28 381 | 200 937 |
| ACM Research | 3 000 | 200 510 |
| Airbnb | 1 168 | 193 000 |
| California Resources | 4 590 | 191 816 |
| ADMA Biologics | 133 563 | 189 659 |
| Acumen Pharmaceuticals | 29 427 | 188 627 |
| Arlo Technologies | 19 733 | 187 661 |
| HEICO | 1 344 | 186 950 |
| Lowe’s | 865 | 181 477 |
| a.k.a. Brands | 20 369 | 180 299 |
| Appfolio | 1 590 | 179 177 |
| A10 Networks | 12 716 | 177 897 |
| AFC Gamma | 8 988 | 175 266 |
| AdvanSix | 4 112 | 174 513 |
| Northfield Bancorp | 9 800 | 171 696 |
| Accel Entertainment | 12 728 | 169 919 |
| Vontier | 4 895 | 166 087 |
| Alerus Financial | 5 797 | 165 215 |
| Innospec | 1 761 | 159 194 |
| Arko | 19 197 | 157 676 |
| ACI Worldwide | 6 045 | 157 291 |
| United Parcel Service | 816 | 156 998 |
| First Bancorp | 5 328 | 155 379 |
| Banc of California | 8 527 | 155 021 |


## L’état des principales cessions reflète les cessions globales d’un titre excédant un pour cent du total des cessions pour

## l’exercice. S’il y avait moins de vingt positions dépassant un pour cent, les vingt positions principales ont été indiquées.